Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Shape Therapeutics
Shape Therapeutics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Shape Therapeutics
Total Funding
$35.5 M
Shape Therapeutics Summary
Company Summary
Overview
Shape Therapeutics is a development-stage biotechnology company. It focuses on RNA-editing gene therapy. Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases.
Type
Private
Status
Active
Founded
2018
HQ
Seattle, WA, US
|
view all locations
Website
https://www.shapetx.com/
Cybersecurity rating
Sectors
Healthcare
drug development
therapy
Homepage
Linkedin
Table of Contents
Key People
Locations
Competitors
Key People
David Huss,
Vice President, Head of Research
Francois Vigneault,
President and CEO
Gary Fortin,
Chief Operating Officer (COO)
John Suliman,
CFO & Head of Business Strategy
and 8 others
Locations
View all
1 location detected
Seattle, WA
HQ
United States
219 Terry Ave N #100
Competitors and Similar Companies
Veralox Therapeutics
Healthcare - Private
RPG Life Sciences
Healthcare - Public
Haoma Medica
Healthcare - Private
AstronauTx
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top